Citations

Showing 10 of 108083 citations.

Levofloxacin-Associated Bullous Pemphigoid in a Hemodialysis Patient After Kidney Transplant Failure
Miao, Jing , Gibson, Lawrence E. , Craici, Iasmina , Craici, Iasmina M, Miao, Jing

Mayo Clinic

American Journal of Case Reports | December 9, 2022 | Volume: 24 | Issue: No issue available | Pages: No page available

10.12659/ajcr.938476 | PMID 36578185 Get It

Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study
Caselli, Richard J. , Chen, Yinghua , Bauer, Robert, Woodruff, Bryan K. , Chen, Kewei , Locke, Dona E.C.

Mayo Clinic

Journal of Alzheimer's Disease | December 9, 2022 | Volume: 91 | Issue: 3 | Pages: 1049-1058

10.3233/jad-220435 | PMID 36502320 Get It

Background: Older age is a major risk factor for severe COVID-19 disease which has been associated with a variety of neurologic complications, both acutely and chronically. Objective: We sought to determine whether milder COVID-19 disease in older vulnerable individuals is also associated with cognitive and behavioral sequelae. Methods: Neuropsychological, behavioral, and clinical outcomes before and after contracting COVID-19 disease, were compared in members of two ongoing longitudinal studies, the Arizona APOE Cohort and the national Alzheimer’s Disease Research Center (ADRC). Results: 152 APOE and 852 ADRC cohort members, mean age overall roughly 70 years, responded to a survey that indicated 21 APOE and 57 ADRC members had contracted COVID-19 before their ensuing (post-COVID) study visit. The mean interval between test sessions that preceded and followed COVID was 2.2 years and 1.2 years respectively for the APOE and ADRC cohorts. The magnitude of change between the pre and post COVID test sessions did not differ on any neuropsychological measure in either cohort. There was, however, a greater increase in informant (but not self) reported cognitive change in the APOE cohort (p = 0.018), but this became nonsignificant after correcting for multiple comparisons. Conclusion: Overall members of both cohorts recovered well despite their greater age-related vulnerability to more severe disease.
Measuring Personalization, Embodiment, and Congruence in Online Learning: A Validation Study
Cook, David A. , Skrupky, Lee P.

Mayo Clinic

Academic Medicine | December 9, 2022 | Volume: 98 | Issue: 3 | Pages: 357-366

10.1097/acm.0000000000005088 | PMID 36484539 Get It

Abstract Purpose Instructional designs promoting personalization (conversational style and visible author), embodiment (human-like mannerisms and presence), and social and cognitive congruence have been shown to enhance learning. However, measurements of these instructional design features are lacking. The authors sought to develop and validate an instrument to measure personalization, embodiment, and congruence in an online course, collecting evidence of content, internal structure, and relationships with other variables. Method Through literature review, expert review, and pilot testing, the authors developed a 15-item, 5-domain instrument. Participants completed this instrument along with assessments of motivation (Instructional Materials Motivation Survey and Motivated Strategies for Learning Questionnaire), knowledge, and course satisfaction immediately after a 30-minute online multimedia learning module comprising slides with voiceover and (for some participants) short video clips, from January to April 2021. Participants included pharmacists, physicians, and advanced practice providers at academic and community hospitals. Confirmatory factor analysis (CFA) was used to examine model fit, followed by structural revisions guided by exploratory factor analysis (EFA) and tested in a new CFA using a split-sample approach. The authors evaluated associations between the revised instrument scores and motivation, knowledge, and satisfaction. Results There were 406 participants. CFA of the original 15-item instrument revealed poor model fit. EFA using 214 randomly selected participants suggested a 2-domain structure. CFA of the revised structure using the other 192 participants revealed good fit for a 9-item, 2-domain instrument: the Congruence–Personalization Questionnaire (CPQ). Linear regression confirmed positive, statistically significant associations for most hypothesized relationships (R2 ≥ 0.12 and P < .001 for 14 of 18 associations with motivation and satisfaction). Associations with knowledge were weak and nonsignificant (R2 ≤ 0.004, P > .23). Conclusions Evidence of content, internal structure, and relationships with other variables support the validity of CPQ scores for measuring personalization and congruence in an online module.
IBD Journal Editorial Fellowship: A Practical Guide for Future Fellows
Kurdi, Ahmed T. , Noor, Nurulamin M , Gold, Stephanie Lauren

Mayo Clinic

Inflammatory Bowel Diseases | December 9, 2022 | Volume: 29 | Issue: 1 | Pages: 172-173

10.1093/ibd/izac249 | PMID 36482778 Get It

Lay Summary Inflammatory Bowel Diseases offers an editorial fellowship for GI and IBD fellows with a background in clinical, translational, and basic research and who are interested to experience the editorial process. Herein, the inaugural fellows compile their experience as a guide for future applicants on the fellowship’s responsibilities and highlights.
Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment
Khanna, Narendra N. , Maindarkar, Mahesh , Viswanathan, Vijay , Paul, Sudip , Bhagawati, Mrinalini , Ahluwalia, Puneet , Ruzsa, Zoltán , Singh, Inder M. , Laird, John R. , Fatemi, Mostafa , Saba, Luca , Agarwal, Vikas , Sharma, Aman , Teji, Jagjit S. , Al-Maini, Mustafa , Rathore, Vijay , Naidu, Subbaram, Liblik, Kiera , Johri, Amer M. , Turk, Monika, Mohanty, Lopamudra , Sobel, David , Miner, Martin , Višković, Klaudija , Tsoulfas, George, Protogerou, Athanase D. , Fouda, Mostafa M. , Suri, Jasjit S. , Paul, Sudip , Bhagawati, Mrinalini , Ruzsa, Zoltan , Fatemi, Mostafa , Agarwal, Vikas , Naidu, Subbaram , Sobel, David W , Tsoulfas, George , Protogerou, Athanasios , Fouda, Mostafa M , Maindarkar, Mahesh A , Fernandes, José Fernandes e , Sharma, Aditya , Kolluri, Raghu , Alizad, Azra , Kitas, George D. , Chaturvedi, Seemant , Kalra, Mannudeep K. , Suri, Jasjit S.

Mayo Clinic

Healthcare | December 9, 2022 | Volume: 10 | Issue: 12 | Pages: 2493

10.3390/healthcare10122493 | PMID 36554017 Get It

Motivation: The price of medical treatment continues to rise due to (i) an increasing population; (ii) an aging human growth; (iii) disease prevalence; (iv) a rise in the frequency of patients that utilize health care services; and (v) increase in the price. Objective: Artificial Intelligence (AI) is already well-known for its superiority in various healthcare applications, including the segmentation of lesions in images, speech recognition, smartphone personal assistants, navigation, ride-sharing apps, and many more. Our study is based on two hypotheses: (i) AI offers more economic solutions compared to conventional methods; (ii) AI treatment offers stronger economics compared to AI diagnosis. This novel study aims to evaluate AI technology in the context of healthcare costs, namely in the areas of diagnosis and treatment, and then compare it to the traditional or non-AI-based approaches. Methodology: PRISMA was used to select the best 200 studies for AI in healthcare with a primary focus on cost reduction, especially towards diagnosis and treatment. We defined the diagnosis and treatment architectures, investigated their characteristics, and categorized the roles that AI plays in the diagnostic and therapeutic paradigms. We experimented with various combinations of different assumptions by integrating AI and then comparing it against conventional costs. Lastly, we dwell on three powerful future concepts of AI, namely, pruning, bias, explainability, and regulatory approvals of AI systems. Conclusions: The model shows tremendous cost savings using AI tools in diagnosis and treatment. The economics of AI can be improved by incorporating pruning, reduction in AI bias, explainability, and regulatory approvals.
Divulging a Pleiotropic Role of Succinate Receptor SUCNR1 in Renal Cell Carcinoma Microenvironment
Najm, Rania , Hachim, Mahmood Yaseen , Kandasamy, Richard K.

Mayo Clinic

Cancers | December 9, 2022 | Volume: 14 | Issue: 24 | Pages: 6064

10.3390/cancers14246064 | PMID 36551549 Get It

The succinate receptor, SUCNR1, has been attributed to tumor progression, metastasis, and immune response modulation upon its activation via the oncometabolite succinate. Nonetheless, little is known about the prognostic relevance of SUCNR1 and its association with tumor immune infiltrates and microbiota in renal cell carcinoma (RCC). Herein, publicly available platforms including Human Protein Atlas, cBioPortal, TIMER2.0, and TISIDB were utilized to depict a divergent implication of SUCNR1 in the immune microenvironment of clear cell RCC (KIRC) and papillary RCC (KIRP); the two major subtypes of RCC. Our results showed that the SUCNR1 expression level was augmented in RCC compared to other solid cancers, yet with opposite survival rate predictions in RCC subtypes. Consequently, a higher expression level of SUCNR1 was associated with a good disease-specific survival rate (p = 5.797 × 10−5) in KIRC patients albeit a poor prognostic prediction in KIRP patients (p = 1.9282 × 10−3). Intriguingly, SUCNR1 was mainly correlated to immunomodulators and diverse immune infiltrates in KIRP. Additionally, the SUCNR1 was mostly associated with a repertoire of microbes including beneficial bacteria that likely influenced a better disease-specific survival rate in KIRC. Our findings illustrate a significant novel subtype-specific role of SUCNR1 in RCC which potentially modulates tumor immune infiltration and microbiome signature, hence altering the prognosis of cancer patients.
Current Diagnosis of Achalasia: Beyond Standard High-Resolution Manometry
Parsa, Nasim , Vela, Marcelo F.

Mayo Clinic

Foregut: The Journal of the American Foregut Society | December 9, 2022 | Volume: 2 | Issue: 4 | Pages: 395-401

10.1177/26345161221143350 Get It

Achalasia is a rare esophageal motility disorder characterized by incomplete relaxation of the lower esophageal sphincter and absence of normal peristalsis. A precise diagnosis is crucial to successful treatment, and over the past few years significant advances have been made in how achalasia is diagnosed. Although high resolution manometry (HRM) is generally considered the gold standard diagnostic modality, manometric findings can be inconclusive and in some cases patients may not tolerate the procedure. Therefore, the addition of provocative maneuvers during HRM, and the use of timed barium esophagram and the functional lumen imaging probe (FLIP) are all important tools that have improved our ability to accurately diagnose achalasia. In this review, we go over the current approach to the diagnosis of achalasia.
A Population-Based Evaluation of Polymicrobial Staphylococcus aureus Bacteremia
Lahr, Brian D. , Baddour, Larry M. , Quintero-Martinez, Juan A , Baddour, Larry , Hindy, Joya-Rita , Quintero-Martinez, Juan Andres , DeSimone, Daniel C.

Mayo Clinic

Pathogens | December 9, 2022 | Volume: 11 | Issue: 12 | Pages: 1499

10.3390/pathogens11121499 | PMID 36558831 Get It

Objective: To provide an evaluation of incidence and six-month mortality rates of polymicrobial Staphylococcus aureus bacteremia (p-SAB) in the United States (US). Methods: A retrospective population-based study of all incident adults with monomicrobial SAB (m-SAB) and p-SAB in Olmsted County, Minnesota (MN) from 1 January 2006, through 31 December 2020, was conducted. Demographics, clinical characteristics, in-hospital outcomes, and six-month survival were compared between groups. Results: Overall, 31 incident p-SAB cases occurred during the 15-year study period, corresponding to an overall age- and sex-standardized incidence rate of 1.9/100,000 person-years (95% CI, 1.3–2.6). One-third of p-SAB cases were due to MRSA, and almost one-half (15/31) were caused by Gram-positive bacteria. As compared to the 541 cases with incident m-SAB, p-SAB patients were more likely to have a catheter-related infection (p = 0.008) and less likely to be community-acquired cases (p = 0.027). The unadjusted risk of six-month mortality was greater in the p-SAB group (14/31, 45.2%) compared to the m-SAB group (144/541, 26.6%) (HR = 1.94, 95% CI = 1.12–3.36, p = 0.018). After adjusting for relevant covariates, this difference approached significance (HR = 1.93, 95% = CI 0.96–3.87, p = 0.064). Conclusions: To our knowledge, the current investigation represents the only US population-based study evaluating p-SAB patients. We found lower incidence rates for p-SAB than previously reported, with almost one-half of the cases caused by Gram-positive bacteria. Furthermore, these patients had poor survival compared to incident m-SAB cases.
Outcome of Preoperative Asymptomatic or Minimally Symptomatic DRUJ Arthritis after Total Wrist Arthrodesis: A Single-Institution Case Series
Dittman, Lauren E. , Rhee, Peter C. , Shin, Alexander Y.

Mayo Clinic

Journal of Wrist Surgery | December 9, 2022 | Volume: 12 | Issue: 04 | Pages: 295-300

10.1055/s-0042-1759687 | PMID 37564618 Get It

Abstract Background Concomitant severe radiocarpal (RC) arthritis with asymptomatic or minimally symptomatic distal radioulnar joint (DRUJ) arthritis can be debilitating for patients. Surgical management of these combined arthritides can pose a dilemma for surgeons and patients. The purpose of this study was to evaluate patients with concomitant RC and DRUJ arthritides who underwent only total wrist arthrodesis (TWA) to determine the need for subsequent surgical management of preoperative asymptomatic/minimally symptomatic DRUJ arthritis. Materials and Methods All patients who underwent TWA between 2008 and 2018 at a single institution were evaluated. Those patients who underwent TWA for degenerative, inflammatory, or posttraumatic arthritis with concomitant asymptomatic or minimally symptomatic DRUJ arthritis preoperatively were included. A retrospective review was performed for demographic variables, TWA indications, pre- versus post-TWA DRUJ symptoms, and severity of DRUJ arthritis on radiographs. Primary outcome measure was survivorship from subsequent DRUJ surgery for development of symptomatic arthritis after initial TWA. Results One hundred and eighty-three patients underwent TWA during the study period, of which 39 wrists met inclusion criteria. Indications for TWA included posttraumatic arthritis (n = 22), avascular necrosis of the lunate (n = 10), and inflammatory arthritis (n = 7). The mean clinical follow-up was 5.7 years (range: 1.5–12.7 years). Four patients (10%) who underwent TWA ultimately required a subsequent procedure to address DRUJ arthritis at a mean time of 20 months (range: 3–60 months) after initial TWA. The initial indication for TWA in these patients included symptomatic posttraumatic arthritis (n = 3) and lunate avascular necrosis (n = 1). Conclusion In patients with symptomatic RC and asymptomatic or minimally symptomatic DRUJ arthritides undergoing TWA alone, 10% in this series required subsequent surgical management for progressive DRUJ arthritis. Clinical Relevance Surgical management of concomitant symptomatic RC and asymptomatic/minimally symptomatic DRUJ arthritides with TWA alone is a reasonable initial approach. Patients should be counseled preoperatively that subsequent surgical management of progressive DRUJ arthritis may be necessary in ∼10% of patients.
Hematology‐oncology pharmacists: We hear you, we see you, we support you
Finnes, Heidi D. , Kennedy, LeAnne , Buie, Larry W., Lawson, Amber , Seung, Amy Hatfield, Davis, Lisa E. , Mackler, Emily , Hough, Shannon , Kennedy, LeAnne , Iannucci, Andrea

Mayo Clinic

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | December 8, 2022 | Volume: 5 | Issue: 12 | Pages: 1325-1326

10.1002/jac5.1707 Get It